Is There a Role for Therapeutic Drug Monitoring of Anti-TNF Monoclonal Antibodies in Inflammatory Bowel Disease

Publisher： Karger

E-ISSN： 1421-9875|33|1|70-77

ISSN： 0257-2753

Source： Digestive Diseases, Vol.33, Iss.1, 2015-09, pp. : 70-77

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Onset of psoriasis in patients with inflammatory bowel disease treated with anti-TNF agents

By Guerra Iván   Gisbert Javier P  

Expert Review of Gastroenterology and Hepatology, Vol. 7, Iss. 1, 2013-01 ,pp. : 41-48

Informa Healthcare

Access to resources Recommend Favorite

Strategic Use of Immunosuppressants and Anti-TNF in Inflammatory Bowel Disease

By  

Digestive Diseases, Vol. 31, Iss. 2, 2013-09 ,pp. : 207-212

Karger

Access to resources Recommend Favorite

Is there a future role for anti-TNF therapy in cardiovascular disease?

By Jacobsson Lennart TH   Jovinge Stefan   Turesson Carl  

Future Rheumatology, Vol. 2, Iss. 3, 2007-06 ,pp. : 265-269

Future Medicine

Access to resources Recommend Favorite

Individual medicine in inflammatory bowel disease: Monitoring bioavailability, pharmacokinetics and immunogenicity of anti-tumour necrosis factor-alpha antibodies

By Bendtzen Klaus   Ainsworth Mark   Steenholdt Casper   Thomsen Ole Østergaard   Brynskov Jørn  

Scandinavian Journal of Gastroenterology, Vol. 44, Iss. 7, 2009-07 ,pp. : 774-781

Informa Healthcare

Access to resources Recommend Favorite

Drug Monitoring in Inflammatory Bowel Disease: Helpful or Dispensable?

By  

Digestive Diseases, Vol. 27, Iss. 3, 2009-09 ,pp. : 394-403

Karger

Access to resources Recommend Favorite